Goldenwell Biotech, Inc.

Goldenwell Biotech, Inc.

GWLL - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$59.4M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Goldenwell Biotech, Inc.Goldenwell Biotech, Inc.-222.2-66%-0.6-0.2
$-0.00

Current Fair Value

100.1% downside

Overvalued by 100.1% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$59.40 Million
Enterprise Value$59.50 Million
Earnings per Share$0
Beta5.07
Outstanding Shares99,000,000

Return

Return on Equity66.50%ROE
Return on Assets-1965.62%
Return on Invested Capital324.54%

Valuation & Multiples

P/E Ratio-222.22P/E Ratio
PEG-75.33PEG
Price to Sales-0.6Price to Sales
Price to Book Ratio-0.6Price to Book Ratio
Enterprise Value to Revenue-32963.55
Enterprise Value to EBIT-214.52
Enterprise Value to Net Income-209
Total Debt to Enterprise0
Debt to Equity-0.23Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Goldenwell Biotech, Inc.

3 employees
CEO: Shuang Liu

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmet...